Authors


Lynn Torbeck

Latest:

QbD: Convincing the Skeptics

Without a rigorous discussion of the pros and cons of QbD, its tremendous benefits will be lost.


Rick Lawless

Latest:

Standardized, Hands-on Biomanufacturing Training is Essential

The development of a skilled labor force is essential for an expanding biopharmaceutical industry.


Leslie E. Madigan

Latest:

Strategies for Sourcing Animal-Origin Free Cell Culture Media Components

How to successfully balance patient safety with supply-chain management


Euan W. Milne

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.



Richard Richieri

Latest:

Purification of IgM Monoclonal Antibodies

Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.


Natarajan Ramasubramanyan, PhD

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.


Jason Kamm

Latest:

Coming to a Biotech Near You: Quality by Design Part 2: Design Space in Development and Manufacturing

Quality by Design and Design Space can be used by companies to enhance process understanding, improve scientific rigor, and enhanced qualitative and quantative performance, as well as cost savings.



Adrian Kirk

Latest:

Benefits of Effective Communication with a Contract Analytical Laboratory

Communication between contract analytical laboratory and client is extremley important when out-of-specification (OOS) results arise.


Hans-Wilhelm Beltz

Latest:

Disposable Bioreactors for Cells and Microbes

Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.


Priyabrata Pattnaik

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.



John Avellanet

Latest:

Getting the Results You Expect from Consultants

There are several steps that you can take to ensure that you get the greatest benefit from consultants.


Stefanie Sze-Khoo

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Tarja Mottram

Latest:

Changing Your Business Model

BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.


Raymond W. Nims, PhD

Latest:

Modeling the Efficacy of HTST for Inactivating Mouse Minute Virus

The authors investigate the sufficiency of high-temperature short-time treatment in inactivate mouse minute virus contamination.


David Moyer

Latest:

Criteria for Selecting a CMO: A Case Study

"A systematic approach taken by a company involved making an assessment of internal capabilities, strengths, and needs before the selection process."


Paul Mensah, PhD

Latest:

Advances in Monoclonal Antibody Purification

New technologies and adaptations of existing technologies can improve platform processes.


Emma Waite

Latest:

Establishing a Successful CRO–Client Relationship

It is essential to build and maintain a good working relationship between the client and contract research organization.



Judith Toffenetti

Latest:

Top 10 Legal Issues Biotech Start-Ups Must Address

A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.


Beatriz Garcia

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


Megumi Noguchi

Latest:

Considerations for Scaling-up Depth Filtration of Harvested Cell Culture Fluid

Data on the performance and variability of different formats.



James Strickler

Latest:

Fusion Tags for Protein Expression and Purification

Gene fusion tags can improve the yield and solubility of many recombinant proteins. This article discusses the most popular fusion tags and the proteases used to remove them, with special reference to recently introduced technologies.





Odalys Ruiz Hernández

Latest:

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.

© 2025 MJH Life Sciences

All rights reserved.